![]() |
Autoimmune Disorders |
Free Subscription
1 Ann Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Autoimmune Disorders is free of charge.
Effect of Cumulative Exposure to Ocrelizumab on Memory B-Cell Repopulation
Dynamics in Multiple Sclerosis.
Ann Neurol. 2025 Jun 11. doi: 10.1002/ana.27281.
PubMed
Abstract available
Extending the role of neurofilament light in multiple sclerosis beyond measuring
irreversible neurodegeneration.
Brain. 2025 Jun 9:awaf224. doi: 10.1093.
PubMed
Discovering the hidden emotional burden: Systematic screening for diabetes
distress in adults with type 1 diabetes in nurse-led routine diabetes care.
Diabet Med. 2025 May 15:e70064. doi: 10.1111/dme.70064.
PubMed
Abstract available
The association of environmental mastery and diabetes distress among young adults
with type 1 diabetes.
Diabet Med. 2025 May 9:e70061. doi: 10.1111/dme.70061.
PubMed
Abstract available
Stability and impact of diabetes distress over time: The potential value and uses
of the type 1 diabetes distress assessment system (T1-DDAS).
Diabet Med. 2025 May 8:e70066. doi: 10.1111/dme.70066.
PubMed
Abstract available
Teaching Kitchens: An innovative program for enhancing self-management skills in
adolescents living with type 1 diabetes (T1D) - A feasibility study.
Diabet Med. 2025 May 3:e70053. doi: 10.1111/dme.70053.
PubMed
Abstract available
Management of diabetic ketoacidosis in adult inpatients: A retrospective analysis
of rates of hypoglycaemia with variable-rate and fixed-rate intravenous insulin
infusion protocols.
Diabet Med. 2025 May 1:e70063. doi: 10.1111/dme.70063.
PubMed
Abstract available
Improving access to diabetes technologies in children and young people with type
1 diabetes: Healthcare professionals' perspectives and views.
Diabet Med. 2025 Apr 25:e70058. doi: 10.1111/dme.70058.
PubMed
Abstract available
Impact of Simplera Sync sensors and Extended Wear Infusion Sets on glycaemia
and system performance of the MiniMed 780G system in children and young adults
with previously high HbA1c.
Diabet Med. 2025;42:e70048.
PubMed
Abstract available
Cardiovascular disease risk prediction and profiling among Asian Indians with
young-onset type 1 and type 2 diabetes.
Diabet Med. 2025 Feb 28:e70020. doi: 10.1111/dme.70020.
PubMed
Abstract available
Electrocardiograpic responses during spontaneous hypoglycaemia in people with
type 1 diabetes and impaired awareness of hypoglycaemia.
Diabet Med. 2025 Feb 27:e70019. doi: 10.1111/dme.70019.
PubMed
Abstract available
Research recommendations from the 2024 Breakthrough T1D, Diabetes UK and Kidney
Research UK, diabetes and kidney disease expert workshop.
Diabet Med. 2025 Feb 27:e70013. doi: 10.1111/dme.70013.
PubMed
Abstract available
Global type 1 diabetes prevalence, incidence, and mortality estimates 2025:
Results from the International diabetes Federation Atlas, 11th Edition, and the
T1D Index Version 3.0.
Diabetes Res Clin Pract. 2025;225:112277.
PubMed
Abstract available
Comparison of information provided on diabetes distress when using PAID-20,
PAID-11 or PAID-5. A registry-based study applying IRT analyses among 10,190
adults with type 1 diabetes in Norway.
Diabetes Res Clin Pract. 2025;225:112267.
PubMed
Abstract available
Satisfaction of adult patients using continuous subcutaneous insulin infusion or
multiple daily injections with type 1 diabetes mellitus.
Diabetes Res Clin Pract. 2025;225:112265.
PubMed
Abstract available
Evaluation of cardiovascular risk according to the 2019 ESC/EASD guidelines in
type 1 diabetes mellitus patients: A population-based survey study.
Diabetes Res Clin Pract. 2025;225:112245.
PubMed
Abstract available
HbA1c variability and all-cause mortality in type 1 and type 2 diabetes: A
population-based cohort study using electronic health records.
Diabetes Res Clin Pract. 2025;225:112229.
PubMed
Abstract available
Revisiting the benefits vs risk profile of sodium-glucose co-transporter
inhibitor use in type 1 diabetes Part A: Benefits of sodium-glucose
co-transporter inhibitor use in type 1 diabetes.
Diabetes Res Clin Pract. 2025;225:112278.
PubMed
Abstract available
Is diabetic ketoacidosis at diagnosis of type 1 diabetes associated with
secondary episodes of ketoacidosis? A nationwide longitudinal study of Swedish
children from 2012 to 2019.
Diabetes Res Clin Pract. 2025;225:112282.
PubMed
Abstract available
Black Death protective gene mutation shows ambiguous role in type 1 diabetes, its
complications, and common viral infections.
Diabetes Res Clin Pract. 2025;225:112287.
PubMed
Abstract available
Mucosal Atrophy of the Fornix as an Important Endoscopic Finding for an
Autoimmune Gastritis Diagnosis.
Intern Med. 2025 Jun 12. doi: 10.2169/internalmedicine.5638.
PubMed
Abstract available
Association between Myasthenia Gravis and Smoking.
Intern Med. 2025 Jun 12. doi: 10.2169/internalmedicine.5310.
PubMed
Abstract available
Clinical uptake of an antigen-based approach to membranous nephropathy: a survey
of general nephrologists and glomerular disease experts.
J Nephrol. 2025 Jun 11. doi: 10.1007/s40620-025-02313.
PubMed
Abstract available
Anti-IL-6R antibody treatment changes microglial phenotype in AQP4
peptide-immunized mice, leading to suppression of myelitis severity.
J Neuroimmunol. 2025;405:578644.
PubMed
Abstract available
Autoimmune encephalitis and delayed diagnosis in common variable
immunodeficiency: A case report and review of literature.
J Neuroimmunol. 2025;406:578662.
PubMed
Abstract available
The immunology and neuropathology of the autoimmune nodopathies.
J Neuroimmunol. 2025;406:578665.
PubMed
Abstract available
An updated, comprehensive meta-analysis of the treatment of anti-NMDAR
encephalitis: Analysis, equipoise, and the urgent need for evidence over
anecdote.
J Neuroimmunol. 2025;405:578651.
PubMed
Abstract available
Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to
event during Rituximab treatment.
J Neurol. 2025;272:451.
PubMed
Abstract available
The impact of autoimmune comorbidities on the onset attack recovery in adults
with AQP4-NMOSD and MOGAD.
J Neurol. 2025;272:453.
PubMed
Abstract available
Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with
multiple sclerosis: definition of different patient archetypes from an Italian
expert group perspective.
J Neurol. 2025;272:446.
PubMed
Abstract available
DAGLA autoantibody experience at Mayo Clinic.
J Neurol. 2025;272:460.
PubMed
Retinal neuronal loss and progression independent of relapse activity in multiple
sclerosis.
J Neurol. 2025;272:454.
PubMed
Abstract available
Changes in corticosteroid and non-steroidal immunosuppressive therapy with
long-term zilucoplan treatment in generalized myasthenia gravis.
J Neurol. 2025;272:457.
PubMed
Abstract available
Phospholipase A2receptor-positive membranous nephropathy detected by laser
microdissection and mass spectrometry in patients negative by immunofluorescence
for phospholipase A2receptor on kidney biopsy.
Kidney Int. 2025 Jun 6:S0085-2538(25)00428-4. doi: 10.1016/j.kint.2025.
PubMed
Abstract available
Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of
healthy volunteers and patients with IgA nephropathy.
Kidney Int. 2025 May 30:S0085-2538(25)00414-4. doi: 10.1016/j.kint.2025.
PubMed
Abstract available
Evaluation of Methodologies in Anti-nephrin Autoantibody Detection.
Kidney Int. 2025 Jun 7:S0085-2538(25)00430-2. doi: 10.1016/j.kint.2025.
PubMed
Abstract available
Cognitive reserve in multiple sclerosis: The role of depression and fatigue.
Mult Scler. 2025 Jun 11:13524585251338757. doi: 10.1177/13524585251338757.
PubMed
Abstract available
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR
T-Cell Therapy.
N Engl J Med. 2025;392:2282-2284.
PubMed
Infection, Relapses, and Pseudo-Relapses in Individuals With Multiple Sclerosis.
Neurol Clin Pract. 2025;15:e200493.
PubMed
Abstract available
Erratum: Herpes Zoster Infections With Multiple Sclerosis Disease-Modifying
Therapies: A Real-World Pharmacovigilance Study.
Neurol Clin Pract. 2025;15:e200505.
PubMed
Abstract available
Nicotine, Alcohol Consumption, and Risk of Myasthenia Gravis: Results From the
Swedish Nationwide GEMG Study.
Neurology. 2025;105:e213771.
PubMed
Abstract available
Treatment Patterns and Disease Burden of Juvenile Myasthenia Gravis in the United
States: A Cohort Study Using Health Care Claims Databases.
Neurology. 2025;105:e213736.
PubMed
Abstract available
Clinical study outcomes in IgA nephropathy: A systematic literature review and
narrative synthesis.
PLoS One. 2025;20:e0323530.
PubMed
Abstract available
Predictors of neuropsychiatric manifestations in pediatric patients with lupus.
PLoS One. 2025;20:e0325915.
PubMed
Abstract available
Editorial Expression of Concern for Poon et al., Targeting the muscarinic M1
receptor with a selective, brain-penetrant antagonist to promote remyelination in
multiple sclerosis.
Proc Natl Acad Sci U S A. 2025;122:e2512750122.
PubMed
Regional Differences in the Management of Thyroid Eye Disease: Results from an
International Clinical Practice Survey of Endocrinologists.
Thyroid. 2025 May 28. doi: 10.1089/thy.2024.0759.
PubMed
Abstract available
Thank you for your interest in scientific medicine.